NAD+ 1G & RETATRUTIDE : A UNITED KINGDOM UPDATE

The emerging interest in NAD+ supplementation, particularly at a significant dosage of 1g , continues to gain momentum within the UK healthcare community. Simultaneously , attention is firmly fixed on Retatrutide, a innovative GLP-1 analogue being viewed by many as a potential successor to Tirzep